Search Results - "Yoshikawa, Fukumi"

Mechanisms of sleep deprivation-induced hepatic steatosis and insulin resistance in mice by Shigiyama, Fumika, Kumashiro, Naoki, Tsuneoka, Yousuke, Igarashi, Hiroyuki, Yoshikawa, Fukumi, Kakehi, Saori, Funato, Hiromasa, Hirose, Takahisa

“…Sleep deprivation is associated with increased risk for type 2 diabetes mellitus. However, the underlying mechanisms of sleep deprivation-induced glucose…”
Get more information

Changes in subjective sleep quality in patients with type 2 diabetes who did not use Sleep agents: a cross-sectional study according to age and clinical background by Yoshikawa, Fukumi, Kumashiro, Naoki, Shigiyama, Fumika, Miyagi, Masahiko, Ando, Yasuyo, Uchino, Hiroshi, Hirose, Takahisa

“…Aim Diabetes and aging are both well-established risk factors for insomnia. Therefore, we investigated the changes in subjective sleep quality in relation to…”
Get full text

Giant Cavernous Hemangioma of the Adrenal Gland in an Elderly Patient by Hashimoto, Ayana, Yoshino, Hiroshi, Yoshikawa, Fukumi, Kumashiro, Naoki, Ando, Yasuyo, Yamabe, Fumito, Akishima-Fukasawa, Yuri, Honma, Naoko, Uchino, Hiroshi, Hirose, Takahisa

“…Cavernous hemangioma is a rare, non-functional, benign adrenal tumor. Adrenal cavernous hemangioma is often diagnosed after surgery with a histologic…”
Get full text

SGLT2 inhibitor versus carbohydrate-restricted isocaloric diet: reprogramming substrate oxidation in type 2 diabetes by Igarashi, Hiroyuki, Uchino, Hiroshi, Kanaguchi, Momoko, Hisanaga, Kaori, Sato, Genki, Yoshikawa, Fukumi, Furuta, Masashi, Washizawa, Naohiro, Usui, Shuki, Miyagi, Masahiko, Hirose, Takahisa

“…Based on the whole-body energy metabolism and insulin action, the difference between increased excretion of carbohydrate in urine by SGLT2i and reduced same…”
Get full text

Sustained fasting glucose oxidation and postprandial lipid oxidation associated with reduced insulin dose in type 2 diabetes with sodium–glucose cotransporter 2 inhibitor: A randomized, open‐label, prospective study by Kanazawa, Ken, Uchino, Hiroshi, Shigiyama, Fumika, Igarashi, Hiroyuki, Ikehara, Kayoko, Yoshikawa, Fukumi, Usui, Shuki, Miyagi, Masahiko, Yoshino, Hiroshi, Ando, Yasuyo, Kumashiro, Naoki, Hirose, Takahisa

“…Aims/Introduction Hyperglycemia impairs energy substrate oxidation as a result of glucotoxicity. We examined whether the reduction of plasma glucose using a…”
Get full text

Dipeptidyl peptidase-4 inhibitor improves glycemic variability in multiple daily insulin-treated type 2 diabetes: a prospective randomized-controlled trial by Yoshikawa, Fukumi, Uchino, Hiroshi, Nagashima, Tomoko, Usui, Shuki, Miyagi, Masahiko, Ando, Yasuyo, Hirose, Takahisa

“…Aims To improve glycemic variability (GV) is crucial in the management of multiple daily insulin (MDI) treatment in diabetes. To evaluate the GV improvement in…”
Get full text

Chronotherapeutic efficacy of suvorexant on sleep quality and metabolic parameters in patients with type 2 diabetes and insomnia by Yoshikawa, Fukumi, Shigiyama, Fumika, Ando, Yasuyo, Miyagi, Masahiko, Uchino, Hiroshi, Hirose, Takahisa, Kumashiro, Naoki

“…•This is the first report on the chronic effects of suvorexant in type 2 diabetes patients.•Suvorexant improved sleep quality, abdominal circumference, and…”
Get full text

Mechanisms of Hepatic Steatosis and Insulin Resistance Induced by Sleep Deprivation in Mice by SHIGIYAMA, FUMIKA, KUMASHIRO, NAOKI, YOSHIKAWA, FUKUMI, TSUNEOKA, YOUSUKE, FUNATO, HIROMASA, HIROSE, TAKAHISA

“…Sleep is an important life style component and its deprivation is a risk for type 2 diabetes. However, the underlying mechanisms and the therapeutic target of…”
Get full text

160-OR: Pretreatment Diabetes Has Lower Mortality Rate, Independent of Immune-Related Adverse Events, in Cancer Patients with Immune-Check Point Inhibitor by HISANAGA, KAORI, UCHINO, HIROSHI, YOSHIKAWA, FUKUMI, SHIGIYAMA, FUMIKA, KUMASHIRO, NAOKI, HIROSE, TAKAHISA, ANDO, YASUYO, MIYAGI, MASAHIKO, ISOBE, KAZUTOSHI, HOMMA, SAKAE

“…Objective: Immune checkpoint inhibitors (ICIs) are novel anticancer agents, also generate peculiar dysimmune toxicities, related to immune-related adverse…”
Get full text

Efficacy of intermittent empagliflozin supplementation on dietary self‐management and glycaemic control in patients with poorly controlled type 2 diabetes: A 24‐week randomized controlled trial by Yoshikawa, Fukumi, Kumashiro, Naoki, Shigiyama, Fumika, Uchino, Hiroshi, Ando, Yasuyo, Yoshino, Hiroshi, Miyagi, Masahiko, Ikehara, Kayoko, Hirose, Takahisa

“…Aims To explore the effects of intermittent use of empagliflozin, a sodium‐glucose co‐transporter‐2 inhibitor, on dietary self‐management and glycaemic control…”
Get full text

Glucose Tolerance and the Risk Factors for Transmission in Japanese SARS-CoV-2/WA-1/2020 Epicenter: A Retrospective Study by Saito, Manabu, Uchino, Hiroshi, Iwata, Yoko, Fuchigami, Ayako, Sato, Genki, Yoshikawa, Fukumi, Miyagi, Masahiko, Miyazaki, Taito, Urita, Yoshihisa, Aoki, Kotaro, Ishii, Yoshikazu, Tateda, Kazuhiro, Hirose, Takahisa

“…The severe pathogenic ancient-type COVID-19, SARS-CoV-2/WA-1/2020 was the predominant gene variant in early 2020 in Japan, however, its transmissibility was…”
Get full text

Pre-Existing Diabetes Limits Survival Rate After Immune Checkpoint Inhibitor Treatment for Advanced Lung Cancer: A Retrospective Study in Japan by Hisanaga, Kaori, Uchino, Hiroshi, Kakisu, Naoko, Miyagi, Masahiko, Yoshikawa, Fukumi, Sato, Genki, Isobe, Kazutoshi, Kishi, Kazuma, Homma, Sakae, Hirose, Takahisa

“…Although immune checkpoint inhibitors (ICIs) are promising in the treatment of advanced cancer, their use is associated with immune-related adverse events…”
Get full text

Pre-Existing Diabetes Limits Survival Rate After Immune Checkpoint Inhibitor Treatment for Advanced Lung Cancer: A Retrospective Study in Japan [Corrigendum] by Hisanaga, Kaori, Uchino, Hiroshi, Kakisu, Naoko, Miyagi, Masahiko, Yoshikawa, Fukumi, Sato, Genki, Isobe, Kazutoshi, Kishi, Kazuma, Homma, Sakae, Hirose, Takahisa

“…Hisanaga K, Uchino H, Kakisu N, et al. Diabetes Metab Syndr Obes. 2021;14:773-781. Page 775, left column, third paragraph, line 4, the text "(p<0.5)" should…”
Get full text